Doxorubicin cardiotoxicity and Camellia sinensis cardioprotection determined by speckle-tracking echocardiography
Keywords:
Flavonoids;, Green tea;, Heart injury;, Radial strain;, Longitudinal strainAbstract
Doxorubicin (Dox) is a medication used in the treatment of cancerous tumors and hematologic malignancies with potentially serious side effects, including the risk of cardiotoxicity. Flavonoids are plant metabolites with antioxidant properties and can be extracted from Camellia sinensis (CS). The aim of this study is to evaluate the possible cardioprotective effect of CS against injuries induced by Dox in rats. A total of 32 animals were distributed into four groups: (1) control - intraperitoneal injection (I.P.) of 0.5 mL saline weekly and 1.0 mL water by gavage daily; (2) CS - 0.5 mL saline I.P. weekly and 200 mg/kg CS by gavage daily; (3) Dox - 5.0 mg/kg Dox I.P. weekly and 1.0 mL water by gavage daily; and (4) Dox+CS -5.0 mg/kg Dox I.P. weekly and 200 mg/kg CS by gavage daily. Clinical examinations, blood profiles, electrocardiograms, echocardiograms, and histological analyses of hearts were performed over 25 days. The animals in the Dox group showed changes in body weight and in erythrogram, leukogram, electrocardiography, and echocardiography readings. However, animals from the dox+CS group had significantly less change in body weight, improved cardiac function, and showed more preserved cardiac tissue. This study demonstrated that CS prevents dox-induced cardiotoxicity, despite enhancing the cytotoxic effect on blood cells.
Downloads
References
Al-Malky HS, Al Harthi SE, Osman AM. Major obstacles to doxorubicin therapy: Cardiotoxicity and drug resistance. J Oncol Pharm Pract. 2020;26(2):434-44.
Almeida ALC, Silva VA, Souza Filho AT, Rios VG, Lopes JRP, Afonseca SO, et al. Subclinical ventricular dysfunction detected by speckle tracking two years after use of anthracycline. Arq Bras Cardiol. 2015;104(4):274-83.
Basu A, Sanchez K, Leyva MJ, Wu M, Betts NM, Aston CE, et al. Green tea supplementation affects body weight, lipids, and lipid peroxidation in obese subjects with metabolic syndrome. J Am Coll Nutr. 2010;29(1):31-40.
Botelho AFM, Lempeck MR, Branco SEMT, Nogueira MM, de Almeida ME, Costa AG, et al. Coenzyme Q10 cardioprotective effects against doxorubicin-induced cardiotoxicity in Wistar rat. Cardiovasc Toxicol. 2020;20(3):222-34.
Ceron JJ, Eckersall PD, Martýnez-Subiela S. Acute phase proteins in dogs and cats: current knowledge and future perspectives. Vet Clin Pathol. 2005;34(2):85-9.
Chacko SM, Thambi PT, Kuttan R, Nishigaki I. Beneficial effects of green tea: a literature review. Chin Med. 2010;5(13):1-9.
Chandran K, Aggarwal D, Migrino RQ, Joseph J, McAllister D, Konorev EA, et al. Doxorubicin inactivates myocardial cytochrome c oxidase in rats: cardioprotection by Mito-Q. Biophys J. 2009;96(4):1388-98.
Del Castillo JM, Herszkowicz N, Ferreira C. Speckle tracking - a contratilidade miocárdica em sintonia fina. Rev Bras Ecocardiogr Imagem Cardiovasc. 2010;23(3):46-4.
Eckersall PD, Bell R. Acute phase proteins: Biomarkers of infection and inflammation in veterinary medicine. Vet J. 2010;185(1):23-7.
Elliott P. Pathogenesis of cardiotoxicity induced by anthracyclines. Semin Oncol. 2006;33(3 Suppl 8), S2-S7.
Eslami V, Bayat F, Asadzadeh B, Saffarian E, Gheymati A, Mahmoudi E, et al. Early prediction of ventricular functional recovery after myocardial infarction by longitudinal strain study. Am J Cardiovasc. 2021;11(4):471-77.
Gallay-Lepoutre J, Bélanger MC, Nadeau ME. Prospective evaluation of Doppler echocardiography, tissue Doppler imaging and biomarkers measurement for the detection of doxorubicin-induced cardiotoxicity in dogs: A pilot study. Res Vet Sci. 2016;105:153-59.
Hazari MS, Haykal-Coates N, Winsett DW, Costa DL, Farraj AK. Continuous electrocardiogram reveals differences in the short-term cardiotoxic response of Wistar-Kyoto and spontaneously hypertensive rats to doxorubicin. Toxicol Sci. 2009;110(1):224-34.
Hou XW, Jiang Y, Wang LF, Xu HY, Lin HM, He XY, et al. Protective role of granulocyte colony-stimulating factor against adriamycin induced cardiac, renal and hepatic toxicities. Toxicol Lett. 2009;187(1):40-4.
Karagoz B, Suleymanoglu S, Uzun G, Bilgi O, Aydinoz S, Haholu A, et al. Hyperbaric oxygen therapy does not potentiate doxorubicin-induced cardiotoxicity in rats. Basic Clin Pharmacol Toxicol. 2008;102(3):287-92.
Kashiura M, Fukushima F, Tamura H, Moriya T. T-wave alternans: A harbinger of polymorphic ventricular tachycardia. Oxf Med Case Rep. 2019;9:410-11.
Kenk M, Thackeray JT, Thorn SL, Dhami K, Chow BJ, Ascah KJ, et al. Alterations of pre- and postsynaptic noradrenergic signaling in a rat model of adriamycin-induced cardiotoxicity. J Nucl Cardiol. 2010;17(2):254-63.
Leader CJ, Moharram M, Coffey S, Sammut IA, Wilkins GW, Walker RJ. Myocardial global longitudinal strain: An early indicator of cardiac interstitial fibrosis modified by spironolactone, in a unique hypertensive rat model. Plos One. 2019;14(8):e0220837.
Lustosa BB, Polegato B, Minicucci M, Rafacho B,Santos PP, Fernandes AA, et al. Green tea (Camellia sinensis) attenuates ventricular remodeling after experimental myocardial infarction. Int J Cardiol. 2016;225:147-53.
Nagueh SF, Shah DJ. Echocardiography first but here comes CMR for grading left ventricular diastolic function. ACC Cardiovasc Imaging. 2020;13(12):2543-45.
Oliveira MS, Carvalho JL, Campos ACA, Gomes DA, Goes AM, Melo MM, Doxorubicin has in vivo toxicological effects on in vivo cultured mesenchymal stem cells. Toxicol Lett. 2014; 224(3):380-86.
Oliveira MS, Melo MB, Carvalho JL, Melo IM, Lavor MSL, Gomes DA, et al. Doxorubicin cardiotoxicity and cardiac function improvement after stem cell therapy diagnosed by strain echocardiography. J. Cancer Sci. Ther. 2013;5(2):52-7.
Ramadan MS, Bertolino L, Zampino R, Durante-Mangoni E. Cardiac sequelae after coronavirus disease 2019 recovery: a systematic review. Clin Microbiol Infect. 2021;27(9):1250-61.
Saeed NM, El-Naga RN, El-Bakly WM, Abdel-Rahman HM, Salah ElDin RA, El-Demerdash E. Epigallocatechin-3-gallate pretreatment attenuates doxorubicin-induced cardiotoxicity in rats: A mechanistic study. Biochem Pharmacol. 2015;95(3):145-55.
Schmidt M, Schmitz HJ, Baumgart A, Guedon D, Netsc, MI, Kreuter MH, et al. Toxicity of green tea extracts and their constituents in rat hepatocytes in primary culture. Food Chem Toxicol. 2005;43(2):307-14.
Singh RB, Sozzi FB, Fedacko J, Hristova K, Fatima G, Pella D, et al. Pre-heart failure at 2D- and 3D-speckle tracking echocardiography: A comprehensive review. Echocardiography. 2022;39(2):302-09.
Sleijfer S, Rizzo E, Litière S, Mathijssen RHJ, Judson IR, Gelderblom H, et al. Predictors for doxorubicin-induced hematological toxicity and its association with outcome in advances soft tissue sarcoma patients; a retrospective analysis of the EORTC-soft tissue and bone sarcoma group database. Acta Oncol. 2018;57(8):1117-26.
Takabayashi F, Tahara S, Kaneko T, Harada N. Effect of green tea catechins on oxidative DNA damage of hamster pancreas and liver induced by N-nitrosobis (2-oxopropyl) amine and/or oxidized soybean oil. Biofactors. 2004;21(1-4):335-37.
Xiang P, Yan H, Karen D, Huang LG, Chen Y, Tu L, et al. Dexrazoxane protects against doxorubicin-induced cardiomyopathy: upregulation of Akt and Erk phosphorylation in a rat model. Cancer Chemother Pharmacol. 2009;63(2):343-49.
Yun SY, Kim SP, Song DK. Effects of (-)-epigallocatechin-3-gallate on pancreatic beta-cell damage in streptozotocin-induced diabetic rats. Eur J Pharmacol. 2006;541(1-2):115-21.
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All content of the journal, except where identified, is licensed under a Creative Commons attribution-type BY.
The on line journal has open and free access.
